Literature DB >> 10330728

Factors associated with use of community support services in an older Australian population.

J J Wang1, P Mitchell, W Smith, S R Leeder.   

Abstract

OBJECTIVE: To assess prevalence and risk factors associated with use of community support services in a representative older Australian population.
METHODS: The Blue Mountains Eye Study surveyed 3,654 people aged > or = 49 years, 82.4% of eligible residents from an area west of Sydney during 1992-94. Questions about use of community support services were asked during face-to-face interview. Information on marital and living status, socio-economic status measures, past medical history and self-ranked health status were also collected.
RESULTS: 186 (5.4%) persons including 124 women (6.3%) and 62 men (4.2%) reported regular use of community support services, including Meals-on-Wheels (n = 52), Home Care (n = 147) or visits from a community nurse (n = 63). All three services were used by 17 persons and two services by 42 persons. There was a marked age-related increase in use of services from 1.8% in persons aged < 60 years to 25.3% in persons aged 80+ years. Factors significantly associated with use of community services in a multivariate model were: age (OR 1.7 per age decade), living alone (OR 2.5), walking disability (OR 4.1), visual impairment (OR 3.0), stroke history (OR 2.2), arthritis history (OR 1.8), low perceived health status (OR 1.7), cancer history (OR 1.7) and a history of any falls in the past 12 months (OR 1.6).
CONCLUSIONS: Our study has found a wide range of health-related factors that impact on the use of community support services, particularly conditions causing difficulty in walking. IMPLICATIONS: These data may assist health planners in identifying target populations for the provision of community support services.

Entities:  

Mesh:

Year:  1999        PMID: 10330728     DOI: 10.1111/j.1467-842x.1999.tb01225.x

Source DB:  PubMed          Journal:  Aust N Z J Public Health        ISSN: 1326-0200            Impact factor:   2.939


  6 in total

1.  Factors associated with undercorrected refractive errors in an older population: the Blue Mountains Eye Study.

Authors:  S Thiagalingam; R G Cumming; P Mitchell
Journal:  Br J Ophthalmol       Date:  2002-09       Impact factor: 4.638

2.  Home and community care services: a major opportunity for preventive health care.

Authors:  Louisa R Jorm; Scott R Walter; Sanja Lujic; Julie E Byles; Hal L Kendig
Journal:  BMC Geriatr       Date:  2010-05-22       Impact factor: 3.921

3.  Caregiver Burden in Patients Receiving Ranibizumab Therapy for Neovascular Age Related Macular Degeneration.

Authors:  Rishma Gohil; Roxanne Crosby-Nwaobi; Angus Forbes; Ben Burton; Phil Hykin; Sobha Sivaprasad
Journal:  PLoS One       Date:  2015-06-09       Impact factor: 3.240

4.  Treatment satisfaction of patients undergoing ranibizumab therapy for neovascular age-related macular degeneration in a real-life setting.

Authors:  Rishma Gohil; Roxanne Crosby-Nwaobi; Angus Forbes; Ben J Burton; Philip Hykin; Sobha Sivaprasad
Journal:  Patient Prefer Adherence       Date:  2016-05-26       Impact factor: 2.711

5.  Frequency and gender differences in the use of professional home care in late life. Findings from three German old-age cohorts.

Authors:  Elżbieta W Buczak-Stec; André Hajek; Alexander Pabst; Christian Brettschneider; Hendrik van den Bussche; Birgitt Wiese; Siegfried Weyerer; Jochen Werle; Andreas Hoell; Michael Pentzek; Angela Fuchs; Melanie Luppa; Margit Löbner; Janine Stein; Franziska Förster; Dagmar Weeg; Edelgard Mösch; Kathrin Heser; Martin Scherer; Wolfgang Maier; Matthias C Angermeyer; Michael Wagner; Steffi G Riedel-Heller; Hans-Helmut König
Journal:  Front Med (Lausanne)       Date:  2022-09-02

6.  Vision and quality of life: development of methods for the VisQoL vision-related utility instrument.

Authors:  Stuart Peacock; Roseanne Misajon; Angelo Iezzi; Jeff Richardson; Graeme Hawthorne; Jill Keeffe
Journal:  Ophthalmic Epidemiol       Date:  2008 Jul-Aug       Impact factor: 1.648

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.